Protect Monkeys From Ebola

A single monoclonal antibody isolated from a human survivor of Ebola virus disease (EVD) completely protects monkeys from the lethal virus, and could hold promise as a potential treatment for infected humans, according to new research.

A compound that blocks the Ebola virus's ability to replicate has been found to provide full protection to monkeys when treated three days after the deadly infection, researchers have reported.

A single monoclonal antibody isolated from a human survivor of Ebola virus disease (EVD) completely protects monkeys from the lethal virus, and could hold promise as a potential treatment for infected humans, according to new research.

A compound that blocks the Ebola virus's ability to replicate has been found to provide full protection to monkeys when treated three days after the deadly infection, researchers have reported.